Please login to the form below

Not currently logged in
Email:
Password:

company strategy

This page shows the latest company strategy news and features for those working in and with pharma, biotech and healthcare.

Biogen joins COVID-19 efforts with $10m support fund

Biogen joins COVID-19 efforts with $10m support fund

According to a statement released by the company yesterday, the funds will be used to address ‘immediate critical needs’, with the majority of the donations to be made in support of ... The move follows an outbreak at the Massachusetts-based biotech

Latest news

  • FDA approves Sanofi’s key cancer drug Sarclisa for myeloma FDA approves Sanofi’s key cancer drug Sarclisa for myeloma

    Importantly, the approval of Sarclisa aligns with Sanofi’s narrower focus – last year, Hudson revealed a new strategy for the company, shedding research in its troubled diabetes and cardiovascular franchises to ... According to the company’s

  • The digital shift in pharma marketing The digital shift in pharma marketing

    One of the panelists who leads omnichannel and data strategy for a large pharma company strongly recommended grabbing every opportunity to know your customer, gather data from various touchpoints, and then ... Digital inspiration for pharma on mobile,

  • Newly-listed BioNTech buys Neon to boost cell therapy assets Newly-listed BioNTech buys Neon to boost cell therapy assets

    share the company secured for shares in its IPO less than two years ago. ... In a statement, BioNTech said the deal would give it a US hub for research and clinical development, with Neon operating as a subsidiary company.

  • Galen completes acquisition of healthcare company POA Pharma Galen completes acquisition of healthcare company POA Pharma

    Global pharmaceutical sales and marketing company Galen has completed a multi-million pound acquisition of healthcare company POA Pharma. . ... He will oversee operations in the region and growth the team in line with the global company strategy.

  • GSK divests travel vaccines to Bavarian Nordic as part of strategic refocus GSK divests travel vaccines to Bavarian Nordic as part of strategic refocus

    The move follows a major ongoing strategy refocus at the British pharma, after CEO Emma Walmsley (pictured left) spearheaded plans to reinvest in the company’s oncology business at the beginning ... Barron has also indicated GSK’s interest in cell

More from news
Approximately 51 fully matching, plus 138 partially matching documents found.

Latest Intelligence

  • Gut instincts lead Takeda to GI pipeline success Gut instincts lead Takeda to GI pipeline success

    Takeda’s Asit Parikh talks about a game changer for IBD patients and the company’s long-term strategy for gene and cell therapy. ... that focused the company’s R&D strategy on cutting-edge, innovative approaches in GI, oncology and the central

  • Why pharma should invest in the education of doctors Why pharma should invest in the education of doctors

    Thinking of sales in this way creates a shift to a longer-term strategy. ... Developing a content strategy. So, how does the modern pharma company go about addressing the challenges behind educational content?

  • Can marketing change the world? Can marketing change the world?

    These are metrics where health brands ought to score highly. However, only one healthcare company (J&J) makes the top 30 meaningful brands of 2019, with tech disruptors making up four ... Summit. “What it unlocked was actually a totally new strategy

  • As the opioid crisis grabs the headlines, the search for safe treatments continues As the opioid crisis grabs the headlines, the search for safe treatments continues

    The company’s mantra ‘Addiction is a treatable chronic condition, not a moral failure’ is sustaining its R&D work and Gilles Picard (pictured above), its head of global strategy and ... European operations, said the company is close to new

  • The rise of CEO activism The rise of CEO activism

    strategy. In recent years, the rise of ‘CEO activism’ has seen business leaders take a stand on political or social issues that are not necessarily related to their business. ... of an issue can help bolster loyalty and trust in a company, or deepen

More from intelligence
Approximately 4 fully matching, plus 37 partially matching documents found.

Latest appointments

  • Ex-BMS exec jumps to Gilead to lead research group Ex-BMS exec jumps to Gilead to lead research group

    At BMS, Quigley held responsibility for setting the strategy for the company’s oncology discovery portfolio and business development activities. ... Higgins (pictured right) joined Gilead in 2010 to lead an expansion of the company’s biology

  • New hires at bluebird bio, BioNTech and Provention Bio New hires at bluebird bio, BioNTech and Provention Bio

    She will replace Andrew Obenshain, who has now joined the company’s global leadership team in Boston, US. ... In his role as CCO at Provention, Hoitt will be responsible for the development and execution of the company’s global commercial strategy

  • New hires at Ferring, Flexion and Immunocore New hires at Ferring, Flexion and Immunocore

    Flexion Therapeutics names chief strategy officer. Biopharmaceutical company Flexion Therapeutics has named Christina Willwerth as its chief strategy officer. ... Willwerth joined Flexion back in 2009 and most recently served as the company’s senior

  • Chameleon reveals new leadership line-up Chameleon reveals new leadership line-up

    He will report into Matt D’Auria, chief executive of Chameleon’s parent company Healthcare Consultancy Group. ... The company’s US executive vice president of commercial development, Guy Slatcher now moves into the role of president, Chameleon US.

  • Exelixis appoints Andrew Peters to newly created position Exelixis appoints Andrew Peters to newly created position

    In this newly created role, Peters will work with the Exelixis leadership team to refine the company’s mid- and long-term strategy, which is focused on advancing the next generation ... team as we work to identify potential future growth opportunities

More from appointments
Approximately 0 fully matching, plus 64 partially matching documents found.

Latest from PMHub

  • Equipping your medical affairs teams with solutions to navigate the healthcare landscape

    The role of an MSL has progressively evolved since it was first established by the Upjohn Company in 1967. ... MSLs are a key resource within an organisation. They are central to providing scientific advice, training and insight generation, which is

  • Spotlight interview: 15 minutes on patient engagement in pharma

    We run cross-functional working groups within the pharmaceutical company, and we facilitate and run co-creation meetings between pharmaceutical clients, patient advocacy groups, and patients. ... Both approaches will help determine what the correct and

  • Valid Insight wins the Queen’s Most Coveted Award for Enterprise Valid Insight wins the Queen’s Most Coveted Award for Enterprise

    Today, Her Majesty the Queen announced approval of the Prime Minister’s recommendation for Valid Insight to be honoured in recognition of the outstanding success of the company’s growth strategy. ... Since being established in 2016, the company has

  • Investing in our People Investing in our People

    A group of people who, when it counts, pull together. Last weekend the team went to Palma, Majorca where we held a workshop and meeting to discuss company strategy and how

  • Practical Patient Centricity

    about their medicine is alien to us”.It is not just company strategy and intent that is the driving force for a more patient centric approach: external pressure is also building ... These may be outside the current scope of the company’s business, so

More from PMHub
Approximately 0 fully matching, plus 14 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics